Since NF-κB is an important mediator in the pathophysiology of DCM (Lorenzo et al., 2011), we studied the expression of NF-κB protein in myocardium from naringin-treated and untreated-control and T2D mice. The gene discussed is NFKB1; the disease is type 2 diabetes mellitus.